Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS1185 Category:

The global market for sepsis diagnostics is expected to hit USD 657.5 million by 2024, growing over the forecast period at a CAGR of 8.82%. Factors such as increased sepsis prevalence, increased government initiatives to raise awareness of sepsis, and high incidence of hospital-acquired infections are expected to drive demand for diagnosis of sepsis.

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 1

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 2

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 3

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 4

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 5

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 6

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 7

Sepsis Diagnostics Market by Technology (Molecular Diagnostic, Microbiology, Biomarkers, Immunoassay), Product (Instruments, Blood Culture Media), Pathogen (Fungal, Bacterial), Method (Automated), Test Type (POC, Lab), End-User - 2019 to 2024 8

1 Global Sepsis Diagnostics Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Sepsis Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Sepsis Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Sepsis Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Sepsis Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Sepsis Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Sepsis Diagnostics Market – By Technology (Market Size – & million/billion)
8.1 Microbiology
8.2 Microfluidics
8.3 Biomarkers
8.4 Molecular Diagnostics
8.5 Immunoassays
8.6 Flow Cytometry

9 Global Sepsis Diagnostics Market – By Product
9.1 Blood Culture Media
9.2 Assays & Reagents
9.3 Instruments
9.4 Software

10 Global Sepsis Diagnostics Market – By Test Type
10.1 Laboratory Tests
10.2 Point-of-care Tests

11 Global Sepsis Diagnostics Market – By End-User
11.1 Hospitals
11.2 Pathology & Reference Laboratories

12 Global Sepsis Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Sepsis Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Sepsis Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Biomérieux
14.3 T2 Biosystems
14.4 Danaher
14.5 Thermo Fisher Scientific
14.6 Bruker
14.7 Abbott
14.8 Immunexpress
14.9 Luminex
14.10 Becton,Dickinson,And Company (Bd)
14.11 Response Biomedical
14.12 Company 11 & more

15 Global Sepsis Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations